Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor 19 (GPR19) is a member of the Class A/1 rhodopsin-like family of G protein-coupled receptors. It is considered an orphan receptor because its endogenous ligand has not been definitively identified, though adropin has been proposed as a candidate. GPR19 functions primarily as a signal transducer located in the plasma membrane and may play roles in regulating circadian rhythms and energy metabolism. Expression studies suggest involvement in neuronal development and possible overexpression in certain cancers. Its precise physiological functions and potential as a therapeutic target remain under active investigation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 19 (GPR19).